FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4367291411> ?p ?o ?g. }

• W4367291411 endingPage "101198" @default.
• W4367291411 startingPage "101198" @default.
• W4367291411 abstract "Metastatic colorectal cancer (mCRC) patients tend to have modest benefits from molecularly driven therapeutics. Patient-derived tumor organoids (PDTOs) represent an unmatched model to elucidate tumor resistance to therapy, due to their high capacity to resemble tumor characteristics.We used viable tumor tissue from two cohorts of patients with mCRC, naïve or refractory to treatment, respectively, for generating PDTOs. The derived models were subjected to a 6-day drug screening assay (DSA) with a comprehensive pipeline of chemotherapy and targeted drugs against almost all the actionable mCRC molecular drivers. For the second cohort DSA data were matched with those from PDTO genotyping.A total of 40 PDTOs included in the two cohorts were derived from mCRC primary tumors or metastases. The first cohort included 31 PDTOs derived from patients treated in front line. For this cohort, DSA results were matched with patient responses. Moreover, RAS/BRAF mutational status was matched with DSA cetuximab response. Ten out of 12 (83.3%) RAS wild-type PDTOs responded to cetuximab, while all the mutant PDTOs, 8 out of 8 (100%), were resistant. For the second cohort (chemorefractory patients), we used part of tumor tissue for genotyping. Four out of nine DSA/genotyping data resulted applicable in the clinic. Two RAS-mutant mCRC patients have been treated with FOLFOX-bevacizumab and mitomycin-capecitabine in third line, respectively, based on DSA results, obtaining disease control. One patient was treated with nivolumab-second mitochondrial-derived activator of caspases mimetic (phase I trial) due to high tumor mutational burden at genotyping, experiencing stable disease. In one case, the presence of BRCA2 mutation correlated with DSA sensitivity to olaparib; however, the patient could not receive the therapy.Using CRC as a model, we have designed and validated a clinically applicable methodology to potentially inform clinical decisions with functional data. Undoubtedly, further larger analyses are needed to improve methodology success rates and propose suitable treatment strategies for mCRC patients." @default.
• W4367291411 created "2023-04-29" @default.
• W4367291411 creator A5004016643 @default.
• W4367291411 creator A5006208754 @default.
• W4367291411 creator A5008603187 @default.
• W4367291411 creator A5011103296 @default.
• W4367291411 creator A5012499549 @default.
• W4367291411 creator A5014230558 @default.
• W4367291411 creator A5020391246 @default.
• W4367291411 creator A5027111896 @default.
• W4367291411 creator A5027311239 @default.
• W4367291411 creator A5027573560 @default.
• W4367291411 creator A5028414313 @default.
• W4367291411 creator A5029434394 @default.
• W4367291411 creator A5030199212 @default.
• W4367291411 creator A5030657436 @default.
• W4367291411 creator A5032164411 @default.
• W4367291411 creator A5036184772 @default.
• W4367291411 creator A5038258515 @default.
• W4367291411 creator A5039923734 @default.
• W4367291411 creator A5042601272 @default.
• W4367291411 creator A5043177546 @default.
• W4367291411 creator A5047539709 @default.
• W4367291411 creator A5048947412 @default.
• W4367291411 creator A5053880366 @default.
• W4367291411 creator A5059645677 @default.
• W4367291411 creator A5067376970 @default.
• W4367291411 creator A5068792216 @default.
• W4367291411 creator A5069926525 @default.
• W4367291411 creator A5071876778 @default.
• W4367291411 creator A5075240224 @default.
• W4367291411 creator A5076690603 @default.
• W4367291411 creator A5087015760 @default.
• W4367291411 creator A5088304855 @default.
• W4367291411 creator A5091638379 @default.
• W4367291411 date "2023-06-01" @default.
• W4367291411 modified "2023-10-17" @default.
• W4367291411 title "Establishment of patient-derived tumor organoids to functionally inform treatment decisions in metastatic colorectal cancer" @default.
• W4367291411 cites W1741548448 @default.
• W4367291411 cites W1934094702 @default.
• W4367291411 cites W1965157206 @default.
• W4367291411 cites W2002513358 @default.
• W4367291411 cites W2035252444 @default.
• W4367291411 cites W2074175804 @default.
• W4367291411 cites W2102354469 @default.
• W4367291411 cites W2788735115 @default.
• W4367291411 cites W2789773980 @default.
• W4367291411 cites W2798041799 @default.
• W4367291411 cites W2887223472 @default.
• W4367291411 cites W2951426376 @default.
• W4367291411 cites W3099376746 @default.
• W4367291411 cites W3178562850 @default.
• W4367291411 cites W3210011078 @default.
• W4367291411 cites W3215141374 @default.
• W4367291411 cites W4223999681 @default.
• W4367291411 cites W4224880107 @default.
• W4367291411 doi "https://doi.org/10.1016/j.esmoop.2023.101198" @default.
• W4367291411 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37119788" @default.
• W4367291411 hasPublicationYear "2023" @default.
• W4367291411 type Work @default.
• W4367291411 citedByCount "2" @default.
• W4367291411 countsByYear W43672914112023 @default.
• W4367291411 crossrefType "journal-article" @default.
• W4367291411 hasAuthorship W4367291411A5004016643 @default.
• W4367291411 hasAuthorship W4367291411A5006208754 @default.
• W4367291411 hasAuthorship W4367291411A5008603187 @default.
• W4367291411 hasAuthorship W4367291411A5011103296 @default.
• W4367291411 hasAuthorship W4367291411A5012499549 @default.
• W4367291411 hasAuthorship W4367291411A5014230558 @default.
• W4367291411 hasAuthorship W4367291411A5020391246 @default.
• W4367291411 hasAuthorship W4367291411A5027111896 @default.
• W4367291411 hasAuthorship W4367291411A5027311239 @default.
• W4367291411 hasAuthorship W4367291411A5027573560 @default.
• W4367291411 hasAuthorship W4367291411A5028414313 @default.
• W4367291411 hasAuthorship W4367291411A5029434394 @default.
• W4367291411 hasAuthorship W4367291411A5030199212 @default.
• W4367291411 hasAuthorship W4367291411A5030657436 @default.
• W4367291411 hasAuthorship W4367291411A5032164411 @default.
• W4367291411 hasAuthorship W4367291411A5036184772 @default.
• W4367291411 hasAuthorship W4367291411A5038258515 @default.
• W4367291411 hasAuthorship W4367291411A5039923734 @default.
• W4367291411 hasAuthorship W4367291411A5042601272 @default.
• W4367291411 hasAuthorship W4367291411A5043177546 @default.
• W4367291411 hasAuthorship W4367291411A5047539709 @default.
• W4367291411 hasAuthorship W4367291411A5048947412 @default.
• W4367291411 hasAuthorship W4367291411A5053880366 @default.
• W4367291411 hasAuthorship W4367291411A5059645677 @default.
• W4367291411 hasAuthorship W4367291411A5067376970 @default.
• W4367291411 hasAuthorship W4367291411A5068792216 @default.
• W4367291411 hasAuthorship W4367291411A5069926525 @default.
• W4367291411 hasAuthorship W4367291411A5071876778 @default.
• W4367291411 hasAuthorship W4367291411A5075240224 @default.
• W4367291411 hasAuthorship W4367291411A5076690603 @default.
• W4367291411 hasAuthorship W4367291411A5087015760 @default.
• W4367291411 hasAuthorship W4367291411A5088304855 @default.
• W4367291411 hasAuthorship W4367291411A5091638379 @default.
• W4367291411 hasBestOaLocation W43672914111 @default.
• W4367291411 hasConcept C104317684 @default.

• next